Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate
A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate

NCT00847613

CompletedPhase 3

Sponsor: Pfizer

Conditions: Arthritis, Rheumatoid

Interventions: CP-690,550, CP-690,550, CP-690,550, CP-690,550, Placebo

Countries: United States, Australia, Brazil, Bulgaria, Canada, Colombia, Czechia, Greece

This study is designed to provide safety and efficacy data to support the development of CP-690,550 in patients with moderate to severe rheumatoid arthritis on background of methotrexate.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Adults with moderate to severe rheumatoid arthritis on a stable dose of methotrexate

Exclusion Criteria:

* Pregnancy, severe acute or chronic medical conditions, including serious infections or clinically significant laboratory abnormalities.
Locations (115)
  • Huntsville, Alabama, United States
  • Tucson, Arizona, United States
  • San Diego, California, United States
  • Santa Maria, California, United States
  • Colorado Springs, Colorado, United States
  • Gainesville, Florida, United States
  • Jacksonville, Florida, United States
  • Sarasota, Florida, United States
  • Tampa, Florida, United States
  • Zephyrhills, Florida, United States
  • Morton Grove, Illinois, United States
  • Dubuque, Iowa, United States
  • Lexington, Kentucky, United States
  • Baltimore, Maryland, United States
  • Wheaton, Maryland, United States
  • Worcester, Massachusetts, United States
  • Bingham Farms, Michigan, United States
  • Kalamazoo, Michigan, United States
  • Edina, Minnesota, United States
  • Columbia, Missouri, United States
  • Columbia, Missouri, United States
  • Lee's Summit, Missouri, United States
  • Omaha, Nebraska, United States
  • Omaha, Nebraska, United States
  • Albany, New York, United States
  • Binghamton, New York, United States
  • Syracuse, New York, United States
  • Dayton, Ohio, United States
  • Pittsburgh, Pennsylvania, United States
  • Wyomissing, Pennsylvania, United States
  • + 85 more on CT.gov